Three Questions Medical Product Business Owners Should Ask About Private Investments

By: John Geis, Principal of Cresset Partners

Owners of privately held medical product companies who either want to take their businesses to the next level or be rewarded for their years of hard work through a liquidity event often look to private investments to make that happen, since the money flowing into medical product companies is substantial. For example, in the medical technologies space, the average deal size in 2017 was $605 million (1).

Although valuations can be very significant, many medical product companies tend to be smaller, family-run businesses. One study that analyzed economic data from the Census Bureau found that 73 percent of medical device firms had fewer than 20 employees, and 88 percent had fewer than 100 employees (2). Owners of these companies are often looking for private investment partners who will not only complement their company culture, but will also respect and honor their vision and give it the time and space to be fully realized.

It’s all about finding the right private capital to support where you want your company to go. It may sound obvious, but not all private investments are created equal, and it is important for medical product company owners to understand that.

For owners who want to invest in private capital but still want a say in the direction of their companies, it is suggested that you explore the following three questions:

DO THEY SUPPORT THE LONG-TERM VISION OF THE COMPANY?

This is key. If a private equity firm or private investor doesn’t see eye to eye with where you want your company to go, that is a clear indication to keep looking. With the amount of private investment dollars out there, it is very likely that there is a better suitor who will embrace your vision.

DO THEY HAVE THE PATIENCE TO SEE THAT VISION THROUGH?

Many private equity firms are only willing to hold an investment for five years before they sell it.

As an owner of a medical product company, you need to decide whether that is enough time to see your vision through.

Alternatively, with a firm like Cresset that is made up of families of investors, we can have a much longer time horizon. We have the patience to really let a business grow and mature.

HOW MUCH CONTROL WILL THEY DEMAND?

Control can be hard to let go of for any business owner, but that is exactly what many private investments will demand. Whether it is a private equity firm or a large, multi-national healthcare company looking for an acquisition, business owners typically will want a controlling interest in a company so they can do exactly what they want, when they want.

It is absolutely possible to remain independent from the big manufacturers and distributors and find a partner who appreciates and encourages what you have to offer in defining the legacy of your business. Seek out a partner who will let you retain a say in the future of your business.

About the author: John Geis, is a Principal of Cresset Partners, where he leads the firm’s private investment activities in healthcare.


References:

(1) Source: McKinsey & Company, 2017: Pitchbook Data; Pregin: S&P Capital IQ

(2) Source: MedPac: Report to the Congress: Medicare and the Health Care Delivery System, June 2017

Hot this week

How AI is Transforming Vision Care | By Matthias Hofmann, Co-founder & CEO of Eyebot

"The way we think about healthcare is evolving rapidly. From AI-assisted diagnostics to telehealth expansion, technology is breaking down barriers and reshaping how people access essential medical services. In eyecare, artificial intelligence is increasingly redefining accessibility, affordability, and accuracy in vision care," writes Matthias Hofmann.

Virtual Reality In Telehealth: Improving Therapy, Pain Management, and Medical Training | By Lindsay Dymowski Constantino, President Centennial Pharmacy Services

While virtual reality in telehealth might seem like a novel technology to incorporate into healthcare, at least one portion of our field has been using it for 250 years. Simulation technology has long been instrumental in medical training since it makes failure safe while students practice key skills.

Knee Osteoarthritis and How Retraining Gait Alleviates Pain | By Cliff Bleustein, MD, MBA — Global President, CEO, and Director at AposHealth, & Adjunct...

According to recent research, 15% of the global population over the age of 30 is affected by osteoarthritis, or OA, the most common form of arthritis. This same study projects that OA will affect nearly 1 billion people by the year 2050. These statistics show that OA is a pressing medical concern that should be a top priority for medical professionals seeking to improve their patients’ quality of life.

6 Month Real World Experience Study Confirms Efficacy and Safety of SING IMT ® for Late-Stage Age-Related Macular Degeneration

Published in the journal Heliyon, the new study found that SING IMT improved both distance and near vision — while exhibiting minimal effects on corneal endothelial cell density and a favorable safety profile.

Putting an End to Infusion Confusion with Smart, Simple Solutions | By Rodney W Schutt

Mr. Schutt writes: "Nurses, clinicians, and caregivers across the globe are busier and under more stress than ever before. Every day, they are expected to provide increasingly high-quality care while their resource levels remain woefully inadequate. When managing a high volume of patients, nurses face constant physical and mental strain that can quickly lead to burnout, in a space where even minor clinical errors can be harmful, even fatal."